We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Usage of summary of product characteristics in English
1
Patients will be randomized to either intravenous ferric carboxymaltose (dose based according to SummaryofProductCharacteristics) or intravenous placebo.